Research in Timişioara, after Professor Virgil Păunescu announced that he administered the anti-David vaccine that he developed on his own.



[ad_1]

In a Facebook post, the head of the OncoGen Institute announced that he had self-vaccinated to see the effects on his own skin and demonstrate to Romanian authorities that his project is valuable, worth investing in. The Timisoara County Hospital, which manages the institute, announced that it will begin an investigation, along with specialists from the city’s university, to ensure that the steps of the investigation are followed.

“Given the complexity of the investigation, to ensure that all steps have been completed, the County Hospital and the Timisoara University of Medicine and Pharmacy will make a joint investigation commission, with specialists, who will go through all the stages and verify how all the procedures were done, “Raul Pătraşcu told Mediafax the manager of the Timişoara County Hospital.

The Timisoara manager also says that Professor Păunescu’s statements should be made with more responsibility, so as not to confuse the public. Because although the Timisoara researchers have had good results over time, the rush to draw conclusions can hurt them.

“The worst thing for a professor-sized researcher would be that the investigation be null and void. It is not an administrative punishment, which of course may exist, according to legal provisions. We hope that is not the case. We also monitor We don’t think that is the case, a vaccine is not obtained so quickly, it is obtained in months and months, with an enormous amount of work, and at the OncoGen Institute,[conditionsforsafeandcannotbeavaccineinthistime Objectivefroma point ofscientificviewIsumingtheexistenceofanexperimentalprototypethatcannotbeenprovidedwithintheInstituteOncogendependingonwhichtheproformhashappened ”

*[condicionesparatalcosaynopuedeserunavacunaenestemomentoObjetivodesdeunpuntodevistacientíficoAlosumolaexistenciadeunprototipoexperimentalquenosepuedeofreceranadiemásyquenosepuedeprobarobjetivamentedentrodelinstitutoOncogenindependientementedeloqueelprofesornohayahecho”agregaRaulPătraşcu[condiţiipentruaşacevaşinupoatefivorbadeunvaccinlaacestmomentObiectivdinpunctdevedereştiinţificCelmultdeexistenţaunuiprototipexperimentalcarenupoatefioferitnimănuialtcuivaşicarenupoatefitestatobiectivîncadrulinstitutluiOncogenindiferentdeceafăcutsănuafăcutdomnulprofesor”adaugăRaulPătraşcu

Or, Professor Păunescu claims that the tocami to be offered to other patients was the first to be vaccinated.

“What I wanted, what would have happened in a month, two, three months, when it had reached the patients, the volunteers, was to see if the effort we are making, with the money we want to give them.” We ask, this whole battle of ours has little chance of success. I wanted to see, putting myself in the place of a volunteer what happens. Whether or not there is a chance of success. If the experiment did not have a positive or encouraging result in the first place, it would not have announced this, secondly, we would have started again with basic and clinical research to see where and why I am not going. “I would not like to research and consume more financial resources and involve institutions without the slightest idea, if there is any chance of success or not,” Irgil Păunescu, the head of the team that designed the vaccine, told Mediafax.

Professor Păunescu from Timisoara found out from the press that the investigation will begin, just as his bosses discovered that he was administering his vaccine.

“They probably want to know and understand what’s going on there. They didn’t get it, although I’ve been saying that we’ve been working on a vaccine for three months, it probably didn’t come as a surprise that we’re doing something new now. We’re a research center, We do not do medical care, accidentally subordinated to the Ministry of Health. This investigation puts me in a position to communicate less or nothing with the press until it ends. It is not very normal if they want to know or consider that something is “I am wrong to find out. It is not right that I find out from the press what they want to know through some people that they are going to send, “added the professor.

Virgil Păunescu was quick to draw conclusions, publicly, because he wants to speed up the creation of the vaccine, he fell behind the competition. In addition, he affirms that in the future he will meet all the conditions for his vaccine to be scientifically validated.

“First of all, I tell you honestly, being a little behind the competition, we are watching what the Oxford people are doing and saying, to be honest, I wanted to do it, because making a vaccine is a” It is difficult and expensive to see in the future. We will follow the rules of the Medicines Agency anyway and take all normal measures, “he said.

The head of the institute in Timisoara presented the advantages of his vaccine.

“The biggest advantage is that it can be made in Romania. The second advantage is that it uses a completely new technology and, most importantly from the virological and epidemiological point of view, the vaccination technology is very mobile. If the virus changes tomorrow ” “In three days I have a new solution. The immune system reacts much stronger than I expected. That was another problem, how we set the doses and, if we think it is correct. We used viral capsule proteins, but they were not extracted from the viral capsule, because the virus was sequenced and put on the Internet. We knew the structure of proteins and these viral proteins were artificially synthesized in Germany, “added Virgil Păunescu.

If the research in Timisoara is validated by the commission of inquiry, the vaccine must first pass phase 1, that is, to demonstrate that it is not dangerous to humans. The most advanced vaccines are in phase three, in which their effectiveness is tested.

For the most important news of the day, broadcast in real time and presented in an equidistant way, I LIKE our Facebook page!

Follow Mediafax on Instagram for spectacular images and stories from around the world!

The content of the www.mediafax.ro website is exclusively for your personal information and use. is Prohibited republish the content of this site in the absence of a MEDIAFAX agreement. To obtain this agreement, contact us at [email protected].



[ad_2]